Effect of interferon �-1a on serum matrix metalloproteinase?9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients

Tissue Inhibitor ◽

Relapsing Remitting ◽

Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing–remitting multiple sclerosis treated with interferon beta

Clinical Neurology and Neurosurgery ◽

10.1016/j.clineuro.2005.01.005 ◽

2006 ◽

Vol 108 (2) ◽

pp. 124-128 ◽

Cited By ~ 42

Author(s):

Cavit Boz ◽

Mehmet Ozmenoglu ◽

Sibel Velioglu ◽

Kagan Kilinc ◽

Asim Orem ◽

...

Keyword(s):

Multiple Sclerosis ◽

Interferon Beta ◽

Tissue Inhibitor ◽

Relapsing Remitting ◽

Evaluation of matrix metalloproteinase-9 plasma levels in untreated new Relapsing–remitting multiple sclerosis patients and their first-degree family

Metabolic Brain Disease ◽

10.1007/s11011-021-00758-9 ◽

2021 ◽

Author(s):

Mahsa Samangooei ◽

Mojtaba Farjam ◽

Zahra Niknam ◽

Masoud Etemadifar ◽

Mohammad hasan Meshkibaf ◽

...

Keyword(s):

Multiple Sclerosis ◽

Plasma Levels ◽

Relapsing Remitting ◽

Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients

Human Antibodies ◽

10.3233/hab-160296 ◽

2017 ◽

Vol 24 (3-4) ◽

pp. 65-70 ◽

Cited By ~ 5

Author(s):

Marzieh Khoshbin Nazdik ◽

Mohammad Taheri ◽

Elham Sajjadi ◽

Shahram Arsang-Jang ◽

Zeinab Kazaei Koohpar ◽

...

Keyword(s):

Multiple Sclerosis ◽

Tissue Inhibitor ◽

Expression Ratio ◽

Metalloproteinase 9 ◽

Rna Levels

Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone

Pharmacopsychiatry ◽

10.1055/s-2003-825439 ◽

2004 ◽

Vol 36 (05) ◽

Author(s):

D Mirowska ◽

W Wicha ◽

A Członkowski ◽

A Członkowska ◽

F Holsboer ◽

...

Keyword(s):

Multiple Sclerosis ◽

Peripheral Blood ◽

High Doses ◽

Changing Disease Modifying Therapy Switching Dynamics for Relapsing-Remitting Multiple Sclerosis Patients

10.26226/morressier.59a3eda8d462b8028d895126 ◽

2017 ◽

Author(s):

Craig Wakeford

Keyword(s):

Multiple Sclerosis ◽

Disease Modifying Therapy ◽

Switching Dynamics ◽

Relapsing Remitting ◽

Disease Modifying ◽

The incidence of cognitive impairment among Hungarian relapsing-remitting multiple sclerosis patients

10.26226/morressier.59a3e8b4d462b8028d894334 ◽

2017 ◽

Author(s):

Dániel Sandi

Keyword(s):

Multiple Sclerosis ◽

Cognitive Impairment ◽

Relapsing Remitting ◽

Increased adherence and better satisfaction outcomes with oral treatments in Relapsing-Remitting Multiple Sclerosis patients

10.26226/morressier.59a3edacd462b8028d8959c3 ◽

2017 ◽

Author(s):

Ines González-Suárez

Keyword(s):

Multiple Sclerosis ◽

Relapsing Remitting ◽

Patient Reported Adherence and Treatment Satisfaction in Irish Relapsing Remitting Multiple Sclerosis Patients treated with Fingolimod

10.26226/morressier.59a3e8b7d462b8028d89583a ◽

2017 ◽

Author(s):

Niamh Murphy

Keyword(s):

Multiple Sclerosis ◽

Treatment Satisfaction ◽

Patient Reported ◽

Relapsing Remitting ◽

Effectiveness and Safety of Long-Term Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients with Highly Active Disease

10.26226/morressier.59a3e8b6d462b8028d8953f4 ◽

2017 ◽

Author(s):

Galina Vorobeychik

Keyword(s):

Multiple Sclerosis ◽

Highly Active ◽

Relapsing Remitting ◽

Active Disease

Effectiveness of walking exercise program in improving fatigue in relapsing remitting multiple sclerosis patients

10.26226/morressier.5b7578655aff7400151f31e8 ◽

2018 ◽

Author(s):

Nevin M. Shalaby ◽

Alaa ElMazny

Keyword(s):

Multiple Sclerosis ◽

Exercise Program ◽

Relapsing Remitting ◽

Walking Exercise ◽